Cargando…
Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
Hepatitis C virus (HCV) is widely used to investigate host–virus interactions. Cellular responses to HCV infection have been extensively studied in vitro. However, in human liver, interferon (IFN)‐stimulated gene expression can mask direct transcriptional responses to infection. To better characteri...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452008/ https://www.ncbi.nlm.nih.gov/pubmed/28360091 http://dx.doi.org/10.15252/emmm.201607006 |
_version_ | 1783240303362179072 |
---|---|
author | Boldanova, Tujana Suslov, Aleksei Heim, Markus H Necsulea, Anamaria |
author_facet | Boldanova, Tujana Suslov, Aleksei Heim, Markus H Necsulea, Anamaria |
author_sort | Boldanova, Tujana |
collection | PubMed |
description | Hepatitis C virus (HCV) is widely used to investigate host–virus interactions. Cellular responses to HCV infection have been extensively studied in vitro. However, in human liver, interferon (IFN)‐stimulated gene expression can mask direct transcriptional responses to infection. To better characterize the direct effects of HCV infection in vivo, we analyze the transcriptomes of HCV‐infected patients lacking an activated endogenous IFN system. We show that expression changes observed in these patients predominantly reflect immune cell infiltrates rather than cell‐intrinsic pathways. We also investigate the transcriptomes of patients with endogenous IFN activation, which paradoxically cannot eradicate viral infection. We find that most IFN‐stimulated genes are induced by both recombinant IFN therapy and the endogenous IFN system, but with lower induction levels in the latter, indicating that the innate immune response in chronic hepatitis C is too weak to clear the virus. We show that coding and non‐coding transcripts have different expression dynamics following IFN treatment. Several microRNA primary transcripts, including that of miR‐122, are significantly down‐regulated in response to IFN treatment, suggesting a new mechanism for IFN‐induced expression fine‐tuning. |
format | Online Article Text |
id | pubmed-5452008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54520082017-06-02 Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver Boldanova, Tujana Suslov, Aleksei Heim, Markus H Necsulea, Anamaria EMBO Mol Med Research Articles Hepatitis C virus (HCV) is widely used to investigate host–virus interactions. Cellular responses to HCV infection have been extensively studied in vitro. However, in human liver, interferon (IFN)‐stimulated gene expression can mask direct transcriptional responses to infection. To better characterize the direct effects of HCV infection in vivo, we analyze the transcriptomes of HCV‐infected patients lacking an activated endogenous IFN system. We show that expression changes observed in these patients predominantly reflect immune cell infiltrates rather than cell‐intrinsic pathways. We also investigate the transcriptomes of patients with endogenous IFN activation, which paradoxically cannot eradicate viral infection. We find that most IFN‐stimulated genes are induced by both recombinant IFN therapy and the endogenous IFN system, but with lower induction levels in the latter, indicating that the innate immune response in chronic hepatitis C is too weak to clear the virus. We show that coding and non‐coding transcripts have different expression dynamics following IFN treatment. Several microRNA primary transcripts, including that of miR‐122, are significantly down‐regulated in response to IFN treatment, suggesting a new mechanism for IFN‐induced expression fine‐tuning. John Wiley and Sons Inc. 2017-03-30 2017-06 /pmc/articles/PMC5452008/ /pubmed/28360091 http://dx.doi.org/10.15252/emmm.201607006 Text en © 2017 The Authors. Published under the terms of the CC BY 4.0 license This is an open access article under the terms of the Creative Commons Attribution 4.0 (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Boldanova, Tujana Suslov, Aleksei Heim, Markus H Necsulea, Anamaria Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver |
title | Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver |
title_full | Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver |
title_fullStr | Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver |
title_full_unstemmed | Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver |
title_short | Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver |
title_sort | transcriptional response to hepatitis c virus infection and interferon‐alpha treatment in the human liver |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452008/ https://www.ncbi.nlm.nih.gov/pubmed/28360091 http://dx.doi.org/10.15252/emmm.201607006 |
work_keys_str_mv | AT boldanovatujana transcriptionalresponsetohepatitiscvirusinfectionandinterferonalphatreatmentinthehumanliver AT suslovaleksei transcriptionalresponsetohepatitiscvirusinfectionandinterferonalphatreatmentinthehumanliver AT heimmarkush transcriptionalresponsetohepatitiscvirusinfectionandinterferonalphatreatmentinthehumanliver AT necsuleaanamaria transcriptionalresponsetohepatitiscvirusinfectionandinterferonalphatreatmentinthehumanliver |